22+Peer-Reviewed Publications
Choose your preferred date and OPD slot — our team will confirm by call.
Home/Research & Publications
22+Peer-Reviewed Publications
7New England Journal Papers
42+Clinical Trials Conducted
20+As Principal Investigator
—— Peer-Reviewed Publications
Dr. Jain’s research appears in the most cited medical journals on earth — the publications that define global cardiac practice.
NEJM
The New England Journal of Medicine — the world’s most influential medical journal. CORONARY, STICH, CANTOS, TIPS and transfusion landmark trials.
JAMA
Journal of the American Medical Association — randomized clinical trial on off-pump vs on-pump bypass, 2014.
Circulation
The American Heart Association’s flagship journal — ischemic heart failure surgery outcomes from the STICH trial.
JACC
Journal of the American College of Cardiology — Yoga-based cardiac rehabilitation and the TRIA polymer mitral valve.
—— Selected Works
And where it all began — as early as 2006, Dr. Jain was publishing first-author papers on Surgical Ventricular Restoration and cardiac volume reduction in the Indian Journal of Thoracic & Cardiovascular Surgery, years before the world’s landmark trials validated the field he had already pioneered.
—— Heart Care Research LLP
Phase I – IV
From PARADIGM-HF and FOURIER to CANTOS and PROMINENT — the therapies now standard in global heart failure and lipid care were tested here.
First-in-Human
Principal Investigator in the first-in-human Dafodil™ valve study, the Foldax TRIA™ aortic and mitral polymer valve investigations, and more.
Global Registries
STICH, CORONARY, RBC, TRICS III, Yoga-CaRe, LAAOS III — the landmark registries that shaped modern surgical practice.
—— Recruiting Today
Research at EPIC never pauses. These trials are actively enrolling under Dr. Jain’s leadership today.
Active · PI
First-in-human study of the Dafodil pericardial bioprosthesis for aortic and mitral valve replacement.
Active · PI
Phase III multicenter trial assessing Lp(a) reduction on major cardiovascular events.
Active · PI
VICTORION-1 & 2 PREVENT — next-generation siRNA cholesterol therapy for high-risk patients.
Active · PI
Phase III trial in heart failure with systemic inflammation — the next frontier of anti-inflammatory cardiology.
Active · PI
Phase II study protecting patients from acute kidney injury following cardiac surgery.
Active
National registries tracking aortic bioprosthesis and TricValve transcatheter outcomes across India.
—— On the Global Stage
When you consult Dr. Jain, you consult the research itself — published in NEJM, JAMA, Circulation and JACC.
Book an Appointment